SL Science Holding management commentary attributes wider first-half 2026 net loss to higher operating expenses

• SL Science Holding management commentary reported net loss widened to $2.16 million from $1.6 million for the six months ended June 30, 2026.
• Revenue rose 22.8% to $1.39 million, driven by larger distributor orders as the wholesale distribution model gained traction.
• Gross margin improved to 40.2% from 34.5%, reflecting more favorable procurement terms from stable supplier relationships, according to management.
• Research and development expenses increased 71.5% to $1.23 million, reflecting higher staff salaries and milestone payments tied to development progress.
• General and administrative expenses rose 16.2%, primarily reflecting higher office salaries following senior management expansion and increased listing-related professional fees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SL Science Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-118805), on October 26, 2026, and is solely responsible for the information contained therein.